
- /
- Supported exchanges
- / US
- / MMIRF.PINK
MedMira Inc (MMIRF PINK) stock market data APIs
MedMira Inc Financial Data Overview
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and REVEALCOVID-19 and Reveal G4 HIV tests. The company distributes its products through a network of medical distributors and strategic business development partners, serving customers in various healthcare sectors, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get MedMira Inc data using free add-ons & libraries
Get MedMira Inc Fundamental Data
MedMira Inc Fundamental data includes:
- Net Revenue: 277 K
- EBITDA: -3 527 505
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-08
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MedMira Inc News

Medmira reports Q2 results
* Medmira press release [https://seekingalpha.com/pr/20152729-medmira-reports-second-quarter-results-fy2025] (OTCPK:MMIRF [https://seekingalpha.com/symbol/MMIRF]): Q2 Revenues in Q2 FY2025 of C$69,...


MedMira Reports Third Quarter Results FY2023
HALIFAX, NS / ACCESSWIRE / June 29, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2023. Corporate Update Summary During the third ...

MedMira Second Quarter 2023 Earnings: CA$0.001 loss per share (vs CA$0.001 loss in 2Q 2022)
MedMira (CVE:MIR) Second Quarter 2023 Results Key Financial Results Revenue: CA$170.5k (down 43% from 2Q 2022). Net loss: CA$490.5k (loss widened by 4.7% from 2Q 2022). CA$0.001 loss per share (in l...

MedMira Reports Second Quarter Results FY2023
HALIFAX, NS / ACCESSWIRE / April 3, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2023. Corporate Update Summary During the seco...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.